{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:22:46Z","timestamp":1772133766782,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12941-017-0222-0","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T07:17:01Z","timestamp":1499843821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Silvio","family":"Vega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Dowzicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"222_CR1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bjid.2013.07.002","volume":"17","author":"RN Jones","year":"2013","unstructured":"Jones RN, Guzman-Blanco M, Gales AC, et al. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis. 2013;17:672\u201381.","journal-title":"Braz J Infect Dis"},{"key":"222_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bjid.2013.10.005","volume":"18","author":"M Guzm\u00e1n-Blanco","year":"2014","unstructured":"Guzm\u00e1n-Blanco M, Labarca JA, Villegas MV, Gotuzzo E, Latin America Working Group on Bacterial Resistance. Extended spectrum \u03b2-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis. 2014;18:421\u201333.","journal-title":"Braz J Infect Dis"},{"key":"222_CR3","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1128\/AAC.01833-15","volume":"59","author":"DJ Biedenbach","year":"2015","unstructured":"Biedenbach DJ, Hoban DJ, Reiszner E, et al. In vitro activity of ceftaroline against Staphylococcus aureus isolates collected in 2012 from Latin American countries as part of the AWARE surveillance program. Antimicrob Agents Chemother. 2015;59:7873\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"222_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-015-0085-1","volume":"14","author":"DJ Hoban","year":"2015","unstructured":"Hoban DJ, Reinert RR, Bouchillon SK, Dowzicky MJ. Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004\u20132013. Ann Clin Microbiol Antimicrob. 2015;14:27.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"222_CR5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791\u20138.","journal-title":"Emerg Infect Dis"},{"key":"222_CR6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3855\/jidc.7213","volume":"10","author":"J Z\u00fa\u00f1iga","year":"2016","unstructured":"Z\u00fa\u00f1iga J, Cruz G, P\u00e9rez C, LCRSP Microbiology Group, Tarajia M. The combined-disk boronic acid test as an accurate strategy for the detection of KPC carbapenemase in Central America. J Infect Dev Ctries. 2016;10:298\u2013303.","journal-title":"J Infect Dev Ctries"},{"key":"222_CR7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/jac\/dks101","volume":"67","author":"F Pasteran","year":"2012","unstructured":"Pasteran F, Albornoz E, Faccone D, et al. Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. J Antimicrob Chemother. 2012;67:1795\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"222_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bjid.2016.09.011","volume":"21","author":"F Rossi","year":"2017","unstructured":"Rossi F, Girardello R, Cury AP, Gioia TS, Almeida JN Jr, Duarte AJ. Emergence of colistin resistance in the largest university hospital complex of S\u00e3o Paulo, Brazil, over 5\u00a0years. Braz J Infect Dis. 2017;21:98\u2013101.","journal-title":"Braz J Infect Dis"},{"key":"222_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/S1413-86702008000500012","volume":"12","author":"F Rossi","year":"2008","unstructured":"Rossi F, Garc\u00eda P, Ronzon B, Curcio D, Dowzicky MJ. Rates of antimicrobial resistance in Latin America (2004\u20132007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis. 2008;12:405\u201315.","journal-title":"Braz J Infect Dis"},{"key":"222_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-0711-11-29","volume":"11","author":"L Fern\u00e1ndez-Canigia","year":"2012","unstructured":"Fern\u00e1ndez-Canigia L, Dowzicky MJ. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob. 2012;11:29.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"222_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bjid.2012.08.017","volume":"17","author":"E Garza-Gonz\u00e1lez","year":"2013","unstructured":"Garza-Gonz\u00e1lez E, Dowzicky MJ. Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010. Braz J Infect Dis. 2013;17:13\u20139.","journal-title":"Braz J Infect Dis"},{"key":"222_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12941-015-0116-y","volume":"14","author":"R Morfin-Otero","year":"2015","unstructured":"Morfin-Otero R, Noriega ER, Dowzicky MJ. Antimicrobial susceptibility trends among Gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Ann Clin Microbiol Antimicrob. 2015;14:53.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"222_CR13","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards\u201410th Edn. CLSI document M07-A10","author":"Clinical Laboratory Standards Institute (CLSI)","year":"2015","unstructured":"Clinical Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards\u201410th Edn. CLSI document M07-A10. 10th ed. Wayne: Clinical Laboratory Standards Institute (CLSI); 2015.","edition":"10"},{"key":"222_CR14","volume-title":"Performance standards for antimicrobial susceptibility testing\u2014Twenty-Sixth Informational Supplement. CLSI document M100S","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2016","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing\u2014Twenty-Sixth Informational Supplement. CLSI document M100S. Wayne: Clinical Laboratory Standards Institute (CLSI); 2016."},{"key":"222_CR15","volume-title":"Tygacil\u00ae. Tigecycline FDA prescribing information","author":"Pfizer Inc.","year":"2016","unstructured":"Pfizer Inc. Tygacil\u00ae. Tigecycline FDA prescribing information. Collegeville: Pfizer Inc.; 2016."},{"key":"222_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(99)00090-5","volume":"35","author":"RN Jones","year":"1999","unstructured":"Jones RN. Disk diffusion susceptibility test development for the new glycylcycline, GAR-936. Diagn Microbiol Infect Dis. 1999;35:249\u201352.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"222_CR17","first-page":"S173","volume":"14","author":"R Picao","year":"2008","unstructured":"Picao R, Sader H, Jones R, Andrade S, Gales A. Analysis of resistance and vancomycin \u201creverse creep\u201d in Latin American Staphylococcus aureus: 10-year report of the SENTRY Antimicrobial Surveillance Program (1997\u20132006). Clin Microbiol Infect. 2008;14:S173.","journal-title":"Clin Microbiol Infect"},{"key":"222_CR18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijantimicag.2016.04.021","volume":"48","author":"HS Sader","year":"2016","unstructured":"Sader HS, Castanheira M, Farrell DJ, Flamm RK, Mendes RE, Jones RN. Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011\u20132014). Int J Antimicrob Agents. 2016;48:144\u201350.","journal-title":"Int J Antimicrob Agents"},{"key":"222_CR19","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.1666","volume":"311","author":"PN Malani","year":"2014","unstructured":"Malani PN. National burden of invasive methicillin-resistant Staphylococcus aureus infection. JAMA. 2014;311:1438\u20139.","journal-title":"JAMA"},{"key":"222_CR20","unstructured":"Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2014."},{"key":"222_CR21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bjid.2015.08.011","volume":"19","author":"D Hoban","year":"2015","unstructured":"Hoban D, Biedenbach D, Sahm D, Reiszner E, Iaconis J. Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America\u2014results of AWARE surveillance 2012. Braz J Infect Dis. 2015;19:596\u2013603.","journal-title":"Braz J Infect Dis"},{"key":"222_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2015.03.025","volume":"82","author":"KM Kazmierczak","year":"2015","unstructured":"Kazmierczak KM, Lob SH, Hoban DJ, Hackel MA, Badal RE, Bouchillon SK. Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008\u20132012. Results of the study for monitoring antimicrobial resistance trends. Diagn Microbiol Infect Dis. 2015;82:209\u201314.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"222_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medmal.2013.11.007","volume":"44","author":"P Nordmann","year":"2014","unstructured":"Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect. 2014;44:51\u20136.","journal-title":"Med Mal Infect"},{"key":"222_CR24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1469-0691.12697","volume":"20","author":"LS Tzouvelekis","year":"2014","unstructured":"Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20:862\u201372.","journal-title":"Clin Microbiol Infect"},{"key":"222_CR25","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO). Antimicrobial resistance: global report on surveillance. Geneva: WHO; 2014."},{"key":"222_CR26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eri.09.108","volume":"8","author":"AP Zavascki","year":"2010","unstructured":"Zavascki AP, Carvalhaes CG, Pic\u00e3o RC, Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010;8:71\u201393.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"222_CR27","doi-asserted-by":"crossref","first-page":"7318075","DOI":"10.1155\/2016\/7318075","volume":"2016","author":"AM Gonzalez-Villoria","year":"2016","unstructured":"Gonzalez-Villoria AM, Valverde-Garduno V. Antibiotic-resistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen. J Pathog. 2016;2016:7318075.","journal-title":"J Pathog"},{"key":"222_CR28","doi-asserted-by":"crossref","first-page":"e00310","DOI":"10.1128\/mSphere.00310-16","volume":"2","author":"A Giammanco","year":"2017","unstructured":"Giammanco A, Cal\u00e0 C, Fasciana T, Dowzicky MJ. Global assessment of the activity of tigecycline against multidrug-resistant Gram-negative pathogens between 2004 and 2014 as part of the Tigecycline Evaluation and Surveillance Trial. mSphere. 2017;2:e00310\u20136.","journal-title":"mSphere"},{"key":"222_CR29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-777X.68538","volume":"2","author":"V Manchanda","year":"2010","unstructured":"Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2:291\u2013304.","journal-title":"J Glob Infect Dis"},{"key":"222_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijid.2016.06.016","volume":"49","author":"M T\u00e4rnberg","year":"2016","unstructured":"T\u00e4rnberg M, Nilsson LE, Dowzicky MJ. Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010\u20132014. Int J Infect Dis. 2016;49:141\u20138.","journal-title":"Int J Infect Dis"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-017-0222-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T14:28:40Z","timestamp":1569767320000},"score":1,"resource":{"primary":{"URL":"http:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-017-0222-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1186\/s12941-017-0222-0","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]},"article-number":"50"}}